Nymox Pharmaceutical (NYMXF) Receivables - Net (2015 - 2020)
Nymox Pharmaceutical (NYMXF) recorded Receivables - Net of $1,000 in Q3 2020, down 85.7% from $7,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Nymox Pharmaceutical (NYMXF) Receivables - Net (2015 - 2020) Analysis & Trends
At the end of FY2019, Nymox Pharmaceutical reported Receivables - Net of $4,368, up 109.6% from FY2018.
- Annual Receivables - Net has a four-year compound annual growth rate of 44.6% (FY2015 to FY2019).
- Across earlier years, Receivables - Net came in at $2,084 in FY2018 (-97.4%), $79,000 in FY2017 (-98.8%), $6.42 million in FY2016 and $1,000 in FY2015.
- Quarterly Receivables - Net has ranged from $1,000 in Q4 2015 to $79,000 in Q4 2017 over the past five years.
- On a year-over-year basis, Receivables - Net has declined for three consecutive quarters, with an average decline of 43.3% over the last eight quarters.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 500.0% in Q4 2016, against a decline of 97.4% in Q4 2018 at the low end.
- Per Business Quant, the preceding three quarters came in at $1,000 (Q2 2020), $1,000 (Q1 2020) and $4,368 (Q4 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | Nymox Pharmaceutical | 6.12 Mn | 5.93 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 1,000.00 |
| Dec 31, 2019 | 4,368.00 |
| Sep 30, 2019 | 7,000.00 |
| Jun 30, 2019 | 10,000.00 |
| Mar 31, 2019 | 10,000.00 |
| Dec 31, 2018 | 2,084.00 |
| Sep 30, 2018 | 9,000.00 |
| Jun 30, 2018 | 16,000.00 |
| Mar 31, 2018 | 15,000.00 |
| Dec 31, 2017 | 79,000.00 |
| Dec 31, 2016 | 6,000.00 |
| Dec 31, 2015 | 1,000.00 |
API Access
Nymox Pharmaceutical Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=NYMXF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "NYMXF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=NYMXF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();